Peter D. Haytaian, EVP & President Carelon & Carelon Rx at Elevance Health, Inc. (ELV), sold 31,504 shares at $500.18 ($15.8M) on 2024-03-04, disclosed to the SEC on 2024-03-05.
Scheduled sale ($15.8M) by EVP & President Carelon & Carelon Rx under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $499.11 | 4,314 | $2.2M | 13.7% |
| 2 | $500.18 | 1,889 | $945K | 6.0% |
| 3 | $500.18 | 1,889 | $945K | 6.0% |
| 4 | $500.18 | 4,206 | $2.1M | 13.4% |
| 5 | $500.18 | 4,206 | $2.1M | 13.4% |
| 6 | $500.18 | 15,000 |
| $7.5M |
| 47.6% |
| Total | $500.03 avg | 31,504 | $15.8M | 100% |
| Filing → |
| ANTM | SELL | 2021-03-23 | $41.4M | — | Filing → |
| ANTM | SELL | 2020-12-17 | $3.6M | — | Filing → |
| ANTM | SELL | 2020-11-18 | $3.4M | — | Filing → |